Finasteride
- Product NDC
- 0615-8562
- 11-digit product format
- 006158562
- Labeler code
- 0615
- Product ID
- 0615-8562_4e1dfb0e-d523-48d2-8c82-c80ee2b49800
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Finasteride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Application
- ANDA076437
- Marketing category
- ANDA
- Marketing start
- 2007-02-28
- Substance
- FINASTERIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- 5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Finasteride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FINASTERIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 57GNO57U7G |
| Rxcui | 310346 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0615-8562-05 | Finasteride | 15 in 1 BLISTER PACK | TABLET | 15 | | 1 |
| 0615-8562-39 | Finasteride | 30 in 1 BLISTER PACK | TABLET | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0615-8562 | FINASTERIDE TABLET [NCS HEALTHCARE OF KY, LLC DBA VANGARD LABS] | 1 | Current NDC, 2 package rows | 20250302_8c3b1f6b-0010-4432-8eda-4af3c3573063.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0615-8562-05 | 00615856205 | 15 TABLET in 1 BLISTER PACK (0615-8562-05) | 15 tablet | 2025-02-11 | No | No | Current |
| 0615-8562-39 | 00615856239 | 30 TABLET in 1 BLISTER PACK (0615-8562-39) | 30 tablet | 2025-02-11 | No | No | Current |